Mosquea Gomez Edwin R, Castellanos Vanessa, Soliman Isaac, Mehta Bijal
Internal Medicine, Hackensack Meridian Mountainside Medical Center, Montclair, USA.
Cureus. 2024 Jun 13;16(6):e62315. doi: 10.7759/cureus.62315. eCollection 2024 Jun.
Myopericarditis, a rare inflammatory condition affecting the heart and its surrounding layers, can lead to serious consequences if not promptly diagnosed and treated. A recent case involved a 28-year-old man with no significant medical history who developed severe chest pain and was diagnosed with myopericarditis induced by the Epstein-Barr virus (EBV). The patient's symptoms, imaging, and lab test results suggest myopericarditis. Initially, he was treated with non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, and upon discharge, he continued with NSAIDs, as well as guideline-directed medical therapy, including an angiotensin-converting enzyme inhibitor, beta blocker, and SGLT2 inhibitor. Close follow-up with the cardiology and heart failure programs was planned. This case highlights the rare occurrence of this condition in individuals with a healthy immune system.
心肌心包炎是一种罕见的炎症性疾病，会影响心脏及其周围组织，如果不及时诊断和治疗，可能会导致严重后果。最近有一个病例，一名28岁、无重大病史的男子出现严重胸痛，被诊断为由爱泼斯坦-巴尔病毒（EBV）引起的心肌心包炎。患者的症状、影像学和实验室检查结果提示为心肌心包炎。最初，他接受了非甾体抗炎药（NSAIDs）和秋水仙碱治疗，出院后继续服用NSAIDs以及指南指导的药物治疗，包括血管紧张素转换酶抑制剂、β受体阻滞剂和SGLT2抑制剂。计划对其进行心脏病学和心力衰竭项目的密切随访。该病例凸显了这种疾病在免疫系统健康的个体中罕见发生的情况。
